Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Gap Inc V.GAP


Primary Symbol: GAP

The Gap, Inc. is a specialty apparel company in America. The Company offers apparel, accessories and personal care products for women, men and children. Its Old Navy, Gap, Banana Republic, and Athleta brands offer clothing, accessories and lifestyle products for men, women and children. It is an omni-channel retailer, with sales to customers both in stores and online, through Company-operated and franchise stores, websites, and third-party arrangements. Its omni-channel services, including buying online pick-up in store, order-in-store, find-in-store, and ship-from-store, as well as enhanced mobile-enabled experiences, are tailored across its collection of brands. Gap includes adult apparel and accessories, GapKids, babyGap, Gap Maternity, GapBody, and GapFit collections. Banana Republic is a premium lifestyle retailer celebrating exploration and self-expression through timeless quality, versatile fabrics, and exceptionally made womenswear, menswear, and home designs.


NYSE:GAP - Post by User

<< Previous
Bullboard Posts
Next >>
Post by SchiffKnowsBeston Oct 31, 2010 9:15pm
870 Views
Post# 17637669

GAP vs SSS

GAP vs SSS

From the insider sell early last week.  Wondering if he's looking to get a chunk of when we finance next.

In terms of the SSS debate....our drug is much more effective and just as non-toxic.....Our drug is also targetting a much bigger audience, with a much more expensive drug....with many more possibilities....both are targetting something that has very few non-toxic alternatives.

SSS is much farther along in their process, and have a portfolio of drugs.  I also like SSS management more, due to a little more sense of urgency.

Our drug will ultimately garnish a better licensing deal.  Time value of money might end up saying otherwise if Sokoll can't get this ship moving.

All I want for Christmas is for us to raise enough money to take us through phase II.  15 cents/share is what I expect.

PharmaGap Inc. (GAP)

Filing Date Transaction Date Insider Name Ownership Type Securities Nature of transaction # or value acquired or disposed of Unit Price
Oct 29/10 Oct 26/10 Letellier, Robert Direct Ownership Common Shares 10 - Disposition in the public market -310,000
.130
<< Previous
Bullboard Posts
Next >>